• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

桥本甲状腺炎相关同步性甲状腺癌的高遗传多样性及无克隆关系证据:一项二代测序分析

High Genetic Diversity and No Evidence of Clonal Relation in Synchronous Thyroid Carcinomas Associated with Hashimoto's Thyroiditis: A Next-Generation Sequencing Analysis.

作者信息

Molnár Csaba, Bádon Emese Sarolta, Mokánszki Attila, Mónus Anikó, Beke Lívia, Győry Ferenc, Nagy Endre, Méhes Gábor

机构信息

Department of Pathology, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

Department of Surgery, Faculty of Medicine, University of Debrecen, H-4032 Debrecen, Hungary.

出版信息

Diagnostics (Basel). 2020 Jan 17;10(1):48. doi: 10.3390/diagnostics10010048.

DOI:10.3390/diagnostics10010048
PMID:31963551
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7167801/
Abstract

The close association between pre-existing Hashimoto's thyroiditis and thyroid cancer is well established. The simultaneous occurrence of multiple neoplastic foci within the same organ suggests a common genotoxic effect potentially contributing to carcinogenesis, the nature of which is still not clear. Next-generation sequencing (NGS) provides a potent tool to demonstrate and compare the mutational profile of the independent neoplastic foci. Our collection of 47 cases with thyroid carcinoma and Hashimoto's thyroiditis included 14 with at least two tumorous foci. Detailed histological analysis highlighted differences in histomorphology, immunoprofile, and biological characteristics. Further, a 67-gene NGS panel was applied to demonstrate the mutational diversity of the synchronic tumors. Significant differences could be detected with a wide spectrum of pathogenic gene variants involved (ranging between 5 and 18, cutoff >5.0 variant allele frequencies (VAF)). Identical gene variants represented in both synchronous tumors of the same thyroid gland were found in only two cases ( and genes). An additional set of major driver mutations was identified at variable allele frequencies in a highly individual setup suggesting a clear clonal independence. The different statuses in coincident thyroid carcinoma foci within the same organ outline a special challenge for molecular follow-up and therapeutic decision-making.

摘要

桥本甲状腺炎与甲状腺癌之间的密切关联已得到充分证实。同一器官内多个肿瘤病灶同时出现提示可能存在一种共同的基因毒性作用,这种作用可能参与致癌过程,但其本质仍不清楚。下一代测序(NGS)为展示和比较独立肿瘤病灶的突变谱提供了有力工具。我们收集的47例甲状腺癌合并桥本甲状腺炎病例中,有14例至少有两个肿瘤病灶。详细的组织学分析突出了组织形态学、免疫表型和生物学特性方面的差异。此外,应用一个包含67个基因的NGS面板来展示同步肿瘤的突变多样性。在涉及的广泛致病基因变异(范围在5到18之间,截断值>5.0变异等位基因频率(VAF))中可检测到显著差异。在同一甲状腺的两个同步肿瘤中仅发现两例存在相同的基因变异(以及 基因)。在高度个体化的情况下,以可变等位基因频率鉴定出另一组主要驱动突变,表明明显的克隆独立性。同一器官内同时存在的甲状腺癌病灶中不同的 状态给分子随访和治疗决策带来了特殊挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51b/7167801/8388b457a7a4/diagnostics-10-00048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51b/7167801/0d6ba320ba90/diagnostics-10-00048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51b/7167801/8388b457a7a4/diagnostics-10-00048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51b/7167801/0d6ba320ba90/diagnostics-10-00048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c51b/7167801/8388b457a7a4/diagnostics-10-00048-g002.jpg

相似文献

1
High Genetic Diversity and No Evidence of Clonal Relation in Synchronous Thyroid Carcinomas Associated with Hashimoto's Thyroiditis: A Next-Generation Sequencing Analysis.桥本甲状腺炎相关同步性甲状腺癌的高遗传多样性及无克隆关系证据:一项二代测序分析
Diagnostics (Basel). 2020 Jan 17;10(1):48. doi: 10.3390/diagnostics10010048.
2
Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: A stem cell hypothesis of papillary carcinoma oncogenesis.p53 同源物 p63 在实性细胞巢、甲状腺乳头状癌及桥本甲状腺炎中的免疫组化检测:甲状腺乳头状癌发生的干细胞假说
Hum Pathol. 2004 Apr;35(4):465-73. doi: 10.1016/j.humpath.2003.10.027.
3
Expression of p63 in papillary thyroid carcinoma and in Hashimoto's thyroiditis: a pathobiologic link?p63在甲状腺乳头状癌和桥本甲状腺炎中的表达:一种病理生物学联系?
Hum Pathol. 2003 Aug;34(8):764-9. doi: 10.1016/s0046-8177(03)00239-9.
4
Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.伴有乳头状甲状腺癌(PTC)样核改变的桥本甲状腺炎表达PTC的分子标志物。
Histopathology. 2004 Jul;45(1):39-46. doi: 10.1111/j.1365-2559.2004.01876.x.
5
Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.桥本甲状腺炎与BRAF(V600E)突变状态对甲状腺乳头状癌侵袭性的联合影响
Head Neck. 2016 Jan;38(1):95-101. doi: 10.1002/hed.23854. Epub 2015 Jun 26.
6
[Clinico-pathological features of papillary thyroid cancer coexistent with Hashimoto's thyroiditis].甲状腺乳头状癌合并桥本甲状腺炎的临床病理特征
Orv Hetil. 2017 Feb;158(5):178-182. doi: 10.1556/650.2017.30647.
7
Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma.桥本甲状腺炎与早期乳头状甲状腺癌有共同特征。
Histopathology. 2002 Oct;41(4):357-62. doi: 10.1046/j.1365-2559.2002.01467.x.
8
Association of Hashimoto's thyroiditis and thyroid cancer.桥本甲状腺炎与甲状腺癌的关联。
Curr Opin Oncol. 2015 Jan;27(1):21-5. doi: 10.1097/CCO.0000000000000150.
9
The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto's Thyroiditis.甲状腺乳头状癌的沃辛样变异型:与合并桥本甲状腺炎患者的经典型对比
Int J Endocrinol. 2015;2015:456027. doi: 10.1155/2015/456027. Epub 2015 Apr 23.
10
Warthin-like papillary thyroid carcinoma with immunoglobulin G4-positive plasma cells possibly related to Hashimoto's thyroiditis.具有免疫球蛋白G4阳性浆细胞的沃辛样甲状腺乳头状癌可能与桥本甲状腺炎相关。
Endocr J. 2018 Feb 26;65(2):175-180. doi: 10.1507/endocrj.EJ17-0319. Epub 2017 Nov 2.

引用本文的文献

1
Next-Generation Sequencing in Tumor Diagnosis and Treatment.肿瘤诊断与治疗中的下一代测序技术
Diagnostics (Basel). 2020 Nov 17;10(11):962. doi: 10.3390/diagnostics10110962.
2
Genome-wide DNA methylation analysis of Hashimoto's thyroiditis during pregnancy.妊娠期桥本甲状腺炎的全基因组 DNA 甲基化分析。
FEBS Open Bio. 2020 Dec;10(12):2780-2790. doi: 10.1002/2211-5463.13018. Epub 2020 Nov 11.

本文引用的文献

1
Targetable molecular alterations in congenital glioblastoma.先天性神经胶质瘤的靶向分子改变。
J Neurooncol. 2020 Jan;146(2):247-252. doi: 10.1007/s11060-019-03377-8. Epub 2019 Dec 24.
2
Multifocality in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma Is an Important Clue for the Diagnosis of Familial Adenomatous Polyposis.筛状-微乳头型甲状腺乳头状癌的多灶性是家族性腺瘤性息肉病的重要诊断线索。
Thyroid. 2019 Nov;29(11):1606-1614. doi: 10.1089/thy.2019.0261. Epub 2019 Oct 15.
3
Integrative analysis of genomic and transcriptomic characteristics associated with progression of aggressive thyroid cancer.
整合分析与侵袭性甲状腺癌进展相关的基因组和转录组特征。
Nat Commun. 2019 Jun 24;10(1):2764. doi: 10.1038/s41467-019-10680-5.
4
Precise Detection of Gene Mutations in Fine-Needle Aspiration Specimens of the Papillary Thyroid Microcarcinoma Using Next-Generation Sequencing.使用下一代测序技术精确检测甲状腺微小乳头状癌细针穿刺标本中的基因突变
Int J Endocrinol. 2019 Feb 19;2019:4723958. doi: 10.1155/2019/4723958. eCollection 2019.
5
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.甲状腺乳头状癌:遗传改变与分子生物标志物研究。
Int J Med Sci. 2019 Feb 28;16(3):450-460. doi: 10.7150/ijms.29935. eCollection 2019.
6
Thyroid Carcinoma Coexisting with Hashimoto's Thyreoiditis: Clinicopathological and Molecular Characteristics Clue up Pathogenesis.甲状腺癌合并桥本甲状腺炎:临床病理和分子特征提示发病机制。
Pathol Oncol Res. 2019 Jul;25(3):1191-1197. doi: 10.1007/s12253-019-00580-w. Epub 2019 Jan 21.
7
Oxidative stress in thyroid carcinomas: biological and clinical significance.甲状腺癌中的氧化应激:生物学和临床意义。
Endocr Relat Cancer. 2019 Mar 1;26(3):R131-R143. doi: 10.1530/ERC-18-0476.
8
RET/PTC Gene Rearrangements in Thyroid Carcinogenesis: Assessment and Clinico-Pathological Correlations.RET/PTC 基因重排在甲状腺癌发生中的作用:评估及其与临床病理的相关性。
Pathol Oncol Res. 2020 Jan;26(1):507-513. doi: 10.1007/s12253-018-0540-3. Epub 2018 Nov 22.
9
Thyroid cancers of follicular origin in a genomic light: in-depth overview of common and unique molecular marker candidates.滤泡性起源的甲状腺癌的基因组视角:常见和独特的分子标志物候选物的深入概述。
Mol Cancer. 2018 Aug 8;17(1):116. doi: 10.1186/s12943-018-0866-1.
10
Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.定制 panel(thyroline)在甲状腺癌中的诊断价值及淋巴结转移预测。
Oncol Rep. 2018 Aug;40(2):659-668. doi: 10.3892/or.2018.6493. Epub 2018 Jun 14.